Avanir
Avanir Pharmaceuticals develops and commercializes medicines for patients with central nervous system disorders.
Business Model:
Revenue: $118M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Avanir Information
Avanir was acquired by
Otsuka Pharmaceutical.
The acquisition happend on 2014-12-01.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 30 Enterprise
City: Aliso Viejo
State: CA
Zip: 92656
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$30M
Raised Total:$32M
Social
Metrics
5,189,045Website Global Rank
1,871Website Monthly Traffic
Twitter Followers
Description
Avanir Pharmaceuticals develops and commercializes medicines for patients with central nervous system disorders.
Contact Phone:
+19493896700
Contact Email:
Avanir went public on 4/14/2000 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/14/2000
Ticker Symbol:
AVNR
Amount Raised:
$200M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2005 | Post-IPO Equity | 2 | $16.2M |
OrbiMed Jennison Associates OrbiMed Jennison Associates |
6/2012 | Post-IPO Debt | 2 | $30M |
Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC |
6/2006 | Grant | $2M |
National Institute of Allergy and Infectious Diseases |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
